Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles, CA, USA.
Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Barcelona, Spain.
Int J Soc Psychiatry. 2020 Jun;66(4):344-348. doi: 10.1177/0020764020907628. Epub 2020 Feb 29.
Psychotic experiences are associated with psychiatric treatment utilization, though findings have not been entirely consistent. Furthermore, it is unclear how psychotic experiences relate to specific types of psychiatric treatment, and whether mental illness moderates these associations.
In total, 1,036 adult residents of Buenos Aires were recruited through convenience sampling in public places. Multivariable logistic regression models examined the associations between psychotic experiences and psychiatric treatment, adjusted for age, sex and education. Analyses were then stratified by diagnosis of mental illness.
Approximately 17.95% ( = 186) of the sample reported at least one psychotic experience over the past week, about 22.39% ( = 232) of the sample was receiving some psychiatric or psychological treatment and 8.59% ( = 89) was receiving psychopharmacological treatment. In the total sample, psychotic experiences were associated with greater odds of being in psychiatric/psychological treatment (adjusted odds ratio (AOR): 1.52; 95% confidence interval (CI): 1.05-2.21) and psychopharmacological treatment (AOR: 2.49; 95% CI: 1.52-4.09), adjusted for age, sex and education. Mental illness did not moderate the association between psychotic experiences and psychiatric/psychological treatment, but did moderate the association between psychotic experiences and psychopharmacological treatment. Among people with mental disorders, psychotic experiences were associated with greater odds of receiving psychopharmacological treatment (AOR: 14.63; 95% CI: 1.73-123.45) versus people without mental disorders (AOR: 1.75; 95% CI: 0.98-3.15).
Psychotic experiences are associated with psychiatric treatment utilization, particularly psychopharmacological treatment among people with a co-occurring mental illnesses. Translational research should explore the utility of psychosis screens in assessing need for medication or clinical responsiveness to medications.
精神病性体验与精神科治疗的利用有关,但研究结果并不完全一致。此外,精神病性体验与特定类型的精神科治疗之间的关系尚不清楚,而且精神疾病是否会调节这些关联也不明确。
本研究通过便利抽样在公共场所招募了 1036 名成年布宜诺斯艾利斯居民。多变量逻辑回归模型调整了年龄、性别和教育程度后,考察了精神病性体验与精神科治疗之间的关联。然后根据精神疾病的诊断对分析进行分层。
在样本中,约 17.95%( = 186)报告过去一周至少有一次精神病性体验,约 22.39%( = 232)正在接受某种精神科或心理治疗,8.59%( = 89)正在接受精神药理学治疗。在总样本中,精神病性体验与接受精神科/心理治疗的可能性更大相关(调整后的优势比(AOR):1.52;95%置信区间(CI):1.05-2.21)和精神药理学治疗(AOR:2.49;95% CI:1.52-4.09),调整了年龄、性别和教育程度。精神疾病并未调节精神病性体验与精神科/心理治疗之间的关联,但调节了精神病性体验与精神药理学治疗之间的关联。在患有精神障碍的人群中,精神病性体验与接受精神药理学治疗的可能性更大相关(AOR:14.63;95% CI:1.73-123.45),而与没有精神障碍的人群相比(AOR:1.75;95% CI:0.98-3.15)。
精神病性体验与精神科治疗的利用有关,特别是在伴有共病的精神疾病患者中与精神药理学治疗有关。转化研究应探索精神病筛查在评估药物治疗需求或对药物治疗的临床反应方面的效用。